Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
Phase II trial of cetuximab plus irinotecan for oxaliplatin- and irinotecan-based chemotherapy-refractory patients with advanced and/or metastatic colorectal cancer: evaluation of efficacy and safety based on KRAS mutation status (T-CORE0801). [electronic resource] by
- Soeda, Hiroshi
- Shimodaira, Hideki
- Gamoh, Makio
- Ando, Hideaki
- Isobe, Hideki
- Suto, Takeshi
- Takahashi, Shin
- Kakudo, Yuichi
- Amagai, Kenji
- Mori, Takahiro
- Watanabe, Mika
- Yamaguchi, Takuhiro
- Kato, Shunsuke
- Ishioka, Chikashi
Producer: 20140903
In:
Oncology vol. 87
Availability: No items available.
|
|
7.
|
Intermittent Withdrawal of Oxaliplatin for Alleviating Neurotoxicity during Oxaliplatin-Based Chemotherapy for Japanese Patients with Inoperable or Metastatic Colorectal Cancer: A Phase 2 Multicenter Study. [electronic resource] by
- Kato, Shunsuke
- Imai, Hiroo
- Gamoh, Makio
- Takahata, Takenori
- Ohori, Hisatsugu
- Yasuda, Katsuhiro
- Niitani, Tomohito
- Murakawa, Yasuko
- Amagai, Kenji
- Isobe, Hideki
- Shindo, Yoshiaki
- Kuroki, Michio
- Sakamoto, Yasuhiro
- Shimodaira, Hideki
- Yoshioka, Takashi
- Ishioka, Chikashi
Producer: 20181001
In:
The Tohoku journal of experimental medicine vol. 245
Availability: No items available.
|